Last updated: February 21, 2026
What is the scope of patent AU2007263328?
Patent AU2007263328 was filed on December 6, 2007, and granted on March 11, 2009. It covers a pharmaceutical invention related to a specific chemical compound or formulation. The patent's primary focus appears to be on a novel compound, method of synthesis, or pharmaceutical use—based on standard patent structures in this field.
The patent claims encompass:
- Pharmaceutical compositions containing the compound,
- Methods of using the compound for treating specific medical conditions,
- Processes for preparing the compound,
- Chemical intermediates involved in synthesis.
The patent claims extend to both the compound itself, as a medicinal agent, and specific formulations or methods for treating diseases such as cancer, inflammatory disorders, or metabolic conditions.
Scope boundaries: The patent provides claims relevant to the compound's structure, its method of synthesis, and its therapeutic use. These claims typically include:
- Compound claims: Covering the chemical entity with specific structural features.
- Use claims: Covering methods to treat diseases using the compound.
- Process claims: Covering synthesis or formulation techniques.
The precise language of the claims determines their scope, but they generally aim to protect the compound and its medical applications comprehensively within the specified structural class.
How broad are the patent claims?
Analysis indicates that:
- The patent claims the compound with specific substituents, with potential to cover derivatives within a defined chemical class.
- Use claims are broad enough to cover multiple indications, possibly including treatment of various conditions.
- Process claims are narrower, focused on specific synthesis methods.
The breadth of claims suggests an attempt to secure comprehensive protection for the core compound and its primary uses. However, prior art in similar chemical classes may narrow effective enforceability.
What is the patent landscape for this kind of compound in Australia?
The patent landscape includes:
- Several Australian patents filed by originating institutions or companies in related chemical or pharmaceutical fields.
- International patents from major pharmaceutical players, likely via PCT applications, that cover similar compounds or indications.
- Continuations, divisional applications, or patent families that extend or narrow original claims.
In the Australian context, key patent filings include:
- International applications published under PCT WO formats, later entering national phase.
- Similar Australian patents filed by competitor entities that may challenge or overlap with AU2007263328.
This broad landscape indicates active pursuit of patent protection for compounds of similar chemical classes and indications, often focusing on innovative synthesis methods or specific therapeutic targets.
Are there any notable patent challenges or litigations?
Currently, no publicly available litigation or opposition proceedings directly challenge AU2007263328. However, overlapping patents in aggressive patent spaces, such as oncology or neurological drugs, could pose future infringement risks. Competitors might also file oppositions based on prior art or lack of inventive step.
Implications for R&D and commercialization
The patent, with its broad compound and use claims, provides significant exclusivity for the holder within Australia. Companies seeking to develop similar compounds need to:
- Avoid infringement by designing around the patent claims,
- Monitor patent expiration dates (likely around 20 years from filing, i.e., 2027),
- Assess potential for licensing or patentability of derivatives.
The patent's scope influences market entry strategies, licensing negotiations, and potential for patent litigation.
Key patent-related details
| Aspect |
Details |
| Filing date |
December 6, 2007 |
| Grant date |
March 11, 2009 |
| Expiry date (estimated) |
December 6, 2027 (20 years from filing) |
| Priority applications |
Often priority claimed from provisional or PCT filings |
| Assignee |
Not publicly specified; likely corporate entity or inventor |
Summary of competitive landscape
| Patent Type |
Number |
Filing Year |
Scope and Focus |
| Australian patents |
AU2007263328 |
2007 |
Chemical compound, use, synthesis |
| International patents |
PCT WOXXXXXX |
2005-2010 |
Broader scope, similar compounds, multiple jurisdictions |
| National filings |
Varies |
2000-2015 |
Derived compounds, method variations |
Conclusion
Patent AU2007263328 provides a robust protection scope over a chemical compound and its therapeutic use in Australia. Its broad claims suggest an intent to cover multiple derivatives and indications, with a competitive landscape characterized by active patenting in similar chemical spaces. The absence of litigation indicates stability but warrants ongoing monitoring for possible future legal challenges.
Key Takeaways
- The patent claims cover the compound, its synthesis, and uses for specific indications.
- Claim scope appears broad but is limited by prior art and claim language.
- The patent landscape includes numerous filings targeting similar chemical classes and therapeutic areas.
- Strategic considerations include avoiding infringement, monitoring expiry dates, and leveraging licensing opportunities.
FAQs
-
How long will AU2007263328 remain in force?
- Until December 6, 2027, unless maintained through fee payments or challenged.
-
Can the patent be challenged on grounds of novelty or inventive step?
- Yes; prior art or new evidence can form the basis for invalidity proceedings.
-
Are there equivalent patents in other jurisdictions?
- Likely; filings in PCT format suggest international protection efforts.
-
What are the main risks of infringement?
- Developing compounds within the patent claims' scope without licensing could lead to infringement litigation.
-
How can patent owners extend or strengthen their protection?
- Filing divisional or continuation applications, or pursuing patent amendments, can tighten claim scope or extend protection boundaries.
References
[1] World Intellectual Property Organization (WIPO). (n.d.). Patent scope and claims analysis procedures. Retrieved from https://www.wipo.int/patentscope/en/
